Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Beyond Air Inc (XAIR)

Beyond Air Inc (XAIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Beyond Cancer, Ltd. Announces Phase 1b Clinical Trial Approval for LV UNO in Combination with PD-1 Therapy for Solid Tumor Patients Quiver Quantitative, Inc. - Wed Dec 4, 1:20AM CST

Phase 1b study of LV UNO in solid tumor patients approved in Israel, assessing efficacy and safety with anti-PD-1 therapy.Quiver AI SummaryBeyond Cancer, Ltd. has announced the approval from the Israeli...

XAIR : 0.4031 (-3.12%)
Beyond Cancer Announces Approval by the Israeli Ministry of Health to Conduct a Phase 1b Clinical Trial Utilizing Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) in Combination with Anti-PD-1 Therapy GlobeNewswire - Tue Dec 3, 3:05PM CST

XAIR : 0.4031 (-3.12%)
Beyond Air, Inc. Receives CE Mark Approval for LungFit® PH System to Treat Newborns with Hypoxic Respiratory Failure and Pulmonary Hypertension, Triggering $1 Million Milestone Payment from Getz Healthcare Quiver Quantitative, Inc. - Mon Dec 2, 4:48PM CST

Beyond Air received CE mark approval for LungFit PH, enabling treatment for newborns and adults with pulmonary hypertension.Quiver AI SummaryBeyond Air, Inc. announced that it has received European CE...

XAIR : 0.4031 (-3.12%)
Beyond Air Receives CE Mark in Europe for the LungFit® PH System GlobeNewswire - Mon Dec 2, 6:30AM CST

XAIR : 0.4031 (-3.12%)
NeuroNOS Appoints Nobel Laureate Professor Roger D. Kornberg to Scientific Advisory Board to Advance Treatments for Autism Spectrum Disorder and Neurological Conditions Quiver Quantitative, Inc. - Tue Nov 26, 4:48PM CST

NeuroNOS appoints Nobel laureate Professor Roger D. Kornberg to its Scientific Advisory Board, enhancing its focus on neurological treatments.Quiver AI SummaryNeuroNOS, a biopharmaceutical company focused...

XAIR : 0.4031 (-3.12%)
NeuroNOS Appoints Nobel Laureate, Roger D. Kornberg, to Scientific Advisory Board GlobeNewswire - Tue Nov 26, 6:30AM CST

XAIR : 0.4031 (-3.12%)
Beyond Air, Inc. CEO Steve Lisi to Participate in Piper Sandler 36th Annual Healthcare Conference Quiver Quantitative, Inc. - Fri Nov 15, 1:20AM CST

Beyond Air's CEO to engage at the Piper Sandler Healthcare Conference on December 4, 2024, discussing the company's innovations.Quiver AI SummaryBeyond Air, Inc. announced that CEO Steve Lisi will engage...

XAIR : 0.4031 (-3.12%)
Beyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Thu Nov 14, 3:05PM CST

XAIR : 0.4031 (-3.12%)
Beyond Air Stock Slides After Q2 Earnings Beat, Retail’s Confident Stocktwits - Tue Nov 12, 12:10PM CST

Retail sentiment on the stock turned ‘extremely bullish’ from ‘bullish’ a day ago.

IWC : 129.75 (+1.54%)
VXF : 192.94 (+1.36%)
XAIR : 0.4031 (-3.12%)
Beyond Air Stock Rises Ahead Of Earnings: Retail Bullish Stocktwits - Mon Nov 11, 3:52PM CST

Retail sentiment on the company inched up on Monday, rising to ‘bullish’ (67/100) from ‘neutral’ (46/100) a day ago.

IWC : 129.75 (+1.54%)
VXF : 192.94 (+1.36%)
XAIR : 0.4031 (-3.12%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot